Heart Transplant Surgery Recovery, Weeks 5–8: Sternal Healing, Cardiac Rehabilitation, and Graft Optimization
Weeks 5–8 after heart transplant surgery make up phase 2 of 4 in a typical 16-week recovery: Sternal Healing, Cardiac Rehabilitation, and Graft Optimization. Your own surgeon's instructions always come first.
Goals for weeks 5–8
- Cardiac rehabilitation after heart transplant is fundamentally different from rehabilitation after coronary artery bypass grafting or valve surgery. The standard protocols used for post-CABG patients are inappropriate for transplant patients because they rely on heart rate targets to guide exercise intensity. The denervated heart's delayed heart rate response makes heart rate targets unreliable, and exercise prescription must instead be based on the Borg Rating of Perceived Exertion (RPE) scale. Patients learn to self-assess their effort on a scale where moderate effort (RPE 12 to 14 on a 6-20 scale) corresponds to a pace they can maintain while still being able to carry on a conversation, and vigorous effort (RPE 15 to 17) corresponds to a pace where conversation becomes difficult.
- The prolonged warm-up is non-negotiable. At least 10 to 15 minutes of low-intensity activity (gentle walking, easy cycling) must precede any increase in exercise intensity. This allows circulating catecholamines to gradually stimulate the heart to increase its rate and contractility. Patients who skip the warm-up and immediately begin vigorous activity may experience exercise intolerance, dyspnea, and lightheadedness because the heart has not had time to augment its output. The cool-down period (another 10 to 15 minutes of gradually decreasing activity) is equally important and allows the heart to gradually reduce its rate as catecholamine levels fall.
- Rehabilitation should include both aerobic exercise (walking, cycling, treadmill) and resistance training for all major muscle groups. Heart failure patients typically have significant skeletal muscle atrophy and deconditioning that requires months of progressive work to reverse. Upper body resistance training is introduced only after sternal precautions have been formally lifted, typically at 6 to 8 weeks with imaging or clinical confirmation of sternal healing.
- Post-transplant metabolic complications are so common that they should be anticipated and managed proactively rather than reactively. Hypertension affects the majority of heart transplant recipients and results from the vasoconstrictive effects of tacrolimus, the fluid-retaining effects of corticosteroids, and the vascular disease that contributed to heart failure in many patients. Blood pressure should be monitored at home twice daily and recorded. Target is typically below 130/80 mmHg. Calcium channel blockers are commonly used first-line, though diltiazem and verapamil increase tacrolimus levels and require dose coordination.
- New-onset diabetes after transplant (NODAT) occurs in approximately 15 to 30 percent of heart transplant recipients, driven by tacrolimus and corticosteroid effects on glucose metabolism. Blood glucose should be monitored regularly, and any persistently elevated readings reported. Early identification and management with lifestyle modification, oral hypoglycemics, or insulin prevents both cardiovascular complications and potential damage to the kidneys (which are already stressed by tacrolimus nephrotoxicity).
- Renal function deserves special attention in heart transplant recipients. Calcineurin inhibitor (CNI) nephrotoxicity is cumulative over years and is one of the leading causes of chronic kidney disease in long-term transplant survivors. Some patients eventually require kidney transplant. Monitoring creatinine and estimated glomerular filtration rate (eGFR) at every clinic visit, maintaining adequate hydration, avoiding nephrotoxic drugs (NSAIDs, certain antibiotics, contrast agents when possible), and keeping tacrolimus levels within the lowest effective range all serve to protect kidney function over the long term.
- Dyslipidemia is common and treated with statin therapy, which serves double duty: managing cholesterol and providing anti-inflammatory and vasculoprotective effects that may slow cardiac allograft vasculopathy. Pravastatin and rosuvastatin are commonly preferred because they have fewer interactions with calcineurin inhibitors than other statins.
- Weight gain is a near-universal problem in the first year. The combination of restored appetite, corticosteroid-driven hunger, improved energy, and the psychological impulse to celebrate recovery through food drives weight gain that contributes to every metabolic complication described above. Dietary counseling and exercise through cardiac rehabilitation are the primary tools to manage this.
What to avoid in weeks 5–8
- Sternal precautions lifting at 6-8 weeks if healing confirmed
- Continue all immunosuppression exactly as prescribed
- Continue infection precautions (easing slightly but still significant)
- No NSAIDs (lifelong)
- No grapefruit (lifelong)
- Sun protection (lifelong)
- No new medications or supplements without transplant team approval
- Prolonged warm-up and cool-down for all exercise (lifelong for denervated heart)
← Weeks 1–4: ICU, Inpatient, and Early Post-Discharge Recovery · Weeks 9–12: Expanding Independence and Functional Recovery →
See the whole recovery timeline →
Follow weeks 5–8 in Surgily
Surgily shows each day's exercises for this phase, lets you log how you feel in 30 seconds and share it with your care team, and tells you clearly when to get help.
Get my recovery plan →